Centene Corporation ($CNC) Stock Forecast: Up 5.0% Today

What is Centene Corporation?

CNC (Carve & Craft Corp)

Why is Centene Corporation going up?

CNC stock is up 5.0% on Apr 16, 2026 16:01

• CNC is a leading manufacturer of precision tools and equipment for woodworking and metalworking industries. The company has been expanding its product line and market presence, driving strong investor interest.
• An announcement of a cash dividend payout by MetroCity Bankshares could have positively impacted CNC's stock, indicating a healthy financial market environment.
• The AI arms race in the healthcare sector causing prior authorization issues and reimbursement cuts may have indirectly boosted CNC's stock as investors seek alternative industries for growth.
• A price target adjustment on HCA Healthcare by Baird could have led investors to reallocate funds to CNC, viewing it as a more promising investment opportunity.
• Assetmark Inc.'s increased stake in Elevance Health might have signaled confidence in the healthcare sector, indirectly benefiting CNC as part of a broader market sentiment shift.

CNC Price Chart

CNC Technical Analysis

CNC News

MetroCity Bankshares sets 29-cent cash payout, payable May 8

MetroCity Bankshares, Inc. (NASDAQ: MCBS) announced a quarterly cash dividend of $0.29 per share, payable on May 8, 2026, to shareholders of record as of April 29, 2026. This declaration was made by the company's board of directors on April 15, 2026, and is part of their regular distribution to investors. MetroCity Bankshares is the holding company for Metro City Bank, which operates 30 branches across multiple states.

https://www.stocktitan.net/news/MCBS/metro-city-bankshares-inc-declares-quarterly-cash-uzvwriqfkjfz.html

AI arms race leading to prior auth problems, reimbursement cuts

A new report from the Peterson Health Technology Institute (PHTI) indicates that the "AI arms race" between payers and providers is exacerbating prior authorization issues and leading to cuts in reimbursement rates. While AI is reducing administrative effort for individual organizations, it is increasing overall healthcare spending due to intensified coding by providers. Payers are responding by using their own AI to identify and adjust high-complexity codes, leading to concerns about widening financial gaps between providers who adopt AI and those who don't.

https://www.techtarget.com/revcyclemanagement/news/366641759/AI-arms-race-leading-to-prior-auth-problems-reimbursement-cuts

Baird Adjusts Price Target on HCA Healthcare to $442 From $450, Maintains Neutral Rating

Baird has adjusted its price target for HCA Healthcare (HCA) to $442, down from $450, while reiterating a Neutral rating on the stock. This update reflects an analyst's revised valuation for the healthcare facilities operator. HCA Healthcare Inc. specializes in owning and operating various healthcare facilities, including hospitals, surgical centers, and endoscopy centers across the United States and the United Kingdom.

https://www.marketscreener.com/news/baird-adjusts-price-target-on-hca-healthcare-to-442-from-450-maintains-neutral-rating-ce7e50dcdc80f422

Phillips 66 (PSX) Is Expected to Benefit from Rising Crack Spreads

Oakmark Select Fund, advised by Harris Associates, highlighted Phillips 66 (NYSE: PSX) as a top contributor in its first-quarter 2026 investor letter, noting its stock price rose due to higher crack spreads, geopolitical risk, and strong fourth-quarter 2025 earnings. The fund believes Phillips 66 is well-positioned to benefit from rising crack spreads and is focused on returning cash flow to shareholders. Despite this, Insider Monkey suggests potentially more promising AI stocks with higher upside potential.

https://www.insidermonkey.com/blog/phillips-66-psx-is-expected-to-benefit-from-rising-crack-spreads-1738524/

Assetmark Inc. Acquires 18,913 Shares of Elevance Health, Inc. $ELV

Assetmark Inc. increased its stake in Elevance Health (NYSE:ELV) by 21.8% in the fourth quarter, acquiring an additional 18,913 shares to hold a total of 105,688 shares valued at approximately $37.05 million. Despite some recent analyst price target cuts, the company reported strong quarterly earnings, beating EPS estimates and increasing its quarterly dividend to $1.72 per share. Elevance Health maintains a consensus "Hold" rating among analysts with a target price of $384.67.

https://www.marketbeat.com/instant-alerts/filing-assetmark-inc-acquires-18913-shares-of-elevance-health-inc-elv-2026-04-15/

Trending Today

Gasoline ($GASOLINE) Commodity Forecast: Up 7.3% Today

The Boeing Company ($BA) Stock Forecast: Up 5.2% Today

Masco Corporation ($MAS) Stock Forecast: Up 10.5% Today

TE Connectivity Ltd. New Switzerland Registered Shares ($TEL) Stock Forecast: Down 9.3% Today

Bitcoin ($BTC) Crypto Forecast: Up 5.3% Today

Enphase Energy Inc. ($ENPH) Stock Forecast: Up 6.2% Today

Coinbase Global Inc. ($COIN) Stock Forecast: Up 5.3% Today

Northrop Grumman Corporation ($NOC) Stock Forecast: Down 5.3% Today

Philip Morris International Inc ($PM) Stock Forecast: Up 6.2% Today

Advanced Micro Devices Inc. ($AMD) Stock Forecast: Up 7.1% Today

Centene Corporation Price History

01.03.2026 - CNC Stock was up 5.7%

• Centene Corporation (CNC) is a diversified healthcare company that provides programs and services to government-sponsored healthcare programs. Today, CNC experienced a strong bullish movement in the market.
• The bullish movement in CNC stock could be attributed to the positive sentiment in the healthcare sector following the strong performance of companies like UnitedHealth Group (UNH) and Elevance Health (ELV).
• The current market trend could be influenced by a recent analysis suggesting UnitedHealth Group might face a significant audit exposure, indirectly boosting CNC and emphasizing strength in the industry.
• Investor confidence in the healthcare sector, including CNC, may have been supported by a notable increase in stake in Elevance Health coupled with their positive Q4 earnings and FY 2026 guidance.
• The overall stability and growth potential of various healthcare companies, such as HCA Healthcare Inc., likely added to the positive market sentiment, further driving CNC's bullish movement.

11.02.2026 - CNC Stock was down 7.3%

• Reduction in stake by Capital World Investors in Molina Healthcare (MOH) may have signaled lack of confidence in the healthcare sector, impacting CNC's stock negatively.
• CNC's stock decline can be attributed to warnings of lower membership in Affordable Care Act plans and higher utilization patterns in specialty pharmacy, raising concerns about future revenue streams.
• The market's mixed performance with Centene lagging behind while BridgeBio Pharma led suggests a sector-specific issue affecting CNC rather than broader market conditions.
• Surge in Valero Energy and Baker Hughes stocks, driven by favorable oil prices, highlights a shift towards traditional energy sources, potentially diverting investor attention away from healthcare and renewable energy sectors like CNC and First Solar.

02.03.2026 - CNC Stock was up 5.2%

• CNC experienced a strong bullish movement today.
• The significant increase in stakes by HF Advisory Group LLC and Rockland Trust Co. in Elevance Health (ELV) could have positively impacted CNC's stock price, as ELV's strong financial performance and raised dividend likely boosted investor confidence in the healthcare sector.
• Leerink's report on UnitedHealth Group (UNH) facing substantial RADV audit exposure might have indirectly benefited CNC, as investors may have shifted their focus towards other healthcare companies with potentially lower audit risks.
• Overall, the positive sentiment surrounding healthcare stocks, driven by strong financial results and strategic investments, likely contributed to CNC's bullish market movement today.

16.03.2026 - CNC Stock was up 5.0%

• CNC is a leading manufacturer of precision tools and equipment for woodworking and metalworking industries. The company has been expanding its product line and market presence, driving strong investor interest.
• An announcement of a cash dividend payout by MetroCity Bankshares could have positively impacted CNC's stock, indicating a healthy financial market environment.
• The AI arms race in the healthcare sector causing prior authorization issues and reimbursement cuts may have indirectly boosted CNC's stock as investors seek alternative industries for growth.
• A price target adjustment on HCA Healthcare by Baird could have led investors to reallocate funds to CNC, viewing it as a more promising investment opportunity.
• Assetmark Inc.'s increased stake in Elevance Health might have signaled confidence in the healthcare sector, indirectly benefiting CNC as part of a broader market sentiment shift.

20.02.2026 - CNC Stock was down 5.2%

• CNC experienced a strong bearish movement today.
• The decrease in CNC's stock price can be attributed to a lowered price target for the company from $45.00 to $41.00, along with a Neutral rating.
• This adjustment, combined with other revisions to price targets from various firms, has resulted in a varied sentiment among analysts regarding CNC's future performance.
• The overall negative trend in the healthcare sector, as illustrated by Molina Healthcare Inc. lagging behind its competitors, may have also adversely affected CNC's stock price today.

26.02.2026 - CNC Stock was up 5.1%

• CNC witnessed a notable uptick in its stock price today, potentially reflecting investor confidence in the company's operational resilience and diversification strategy in light of industry challenges.
• The recent 3.00% decline in CNC shares on March 25 appears to be a temporary market response, as financial analysts remain positive with an average target price of $45.71, suggesting considerable growth potential.
• The forthcoming April 25 earnings release is pivotal for CNC, with investors keenly observing how the company addresses rising Medicaid expenses and changes in its membership profile, seeking indications of financial stability and strategic direction in government healthcare.

23.02.2026 - CNC Stock was down 5.1%

• CNC stock faced a bearish movement possibly due to analyst pressure amid healthcare sector headwinds and mixed forecasts, leading to a cautious "Hold" consensus.
• The increased scrutiny on Acadia Healthcare Co, a competitor in the behavioral health sector, due to a US Justice Department probe may have raised concerns about regulatory risks in the industry, impacting CNC's stock valuation.
• The comparison between UnitedHealth Group (UNH) and CNC, with UNH being highlighted for its consistent growth and profitability, might have also influenced investors to shift towards more stable options in the healthcare sector.
• The overall uncertainty in the healthcare industry, coupled with Centene's specific challenges such as Medicaid reimbursement issues and rising medical costs, could have contributed to the bearish movement in CNC stock today.

23.02.2026 - CNC Stock was down 5.0%

• Challenges in Medicaid reimbursement and rising medical costs are putting pressure on Centene Corp., resulting in a cautious sentiment and a consensus to "Hold."
• The decline in CNC's stock could be influenced by mixed performance indicators, including bearish trends in MACD, Bollinger Bands, and KST.
• The scrutiny faced by companies like Acadia Healthcare Co and HCA Healthcare Inc, within the healthcare sector due to regulatory issues and operational uncertainties, may have contributed to the negative sentiment surrounding CNC.
• The prevailing headwinds in the healthcare sector and uncertainties in the US healthcare landscape could have played a role in the drop in Centene Corp.’s stock value today.

12.02.2026 - CNC Stock was down 5.2%

• A price target cut on Centene Corp. following its fourth-quarter results and concerns about future challenges likely contributed to the bearish movement.
• The overall U.S. HMO industry, including Centene, is facing challenges such as escalating medical costs and regulatory hurdles, despite leveraging technology and M&A for expansion.
• Reducing its stake in UnitedHealth Group may have impacted market sentiment towards health insurance companies like Centene.
• Despite the industry's challenges, Centene and other key HMO companies are positioned for long-term growth, as highlighted by Zacks Equity Research, which could provide some optimism for investors amidst the bearish market movement.

24.02.2026 - CNC Stock was down 5.6%

• The bearish movement in CNC's stock could be influenced by the overall mixed market sentiment towards healthcare companies and regulatory pressures.
• The positive earnings report from Jabil Inc. and the subsequent sector-wide rally might have shifted investor focus away from CNC, impacting its stock performance negatively.
• CNC might also be facing specific challenges or concerns within the healthcare sector, leading to a reevaluation of its prospects by investors.
• While CNC's performance today was bearish, it could present a potential buying opportunity for investors looking to capitalize on any short-term market fluctuations in the healthcare industry.

10.02.2026 - CNC Stock was down 12.3%

• Today, Centene Corporation (CNC) experienced a strong bearish movement in the market, likely influenced by several factors:
• CNC's participation in the Barclays Global Healthcare Conference may have led to profit-taking by investors, as the reaffirmed guidance may not have met heightened expectations.
• The partial redemption of $1 billion of its notes could have raised concerns about the company's financial position and future growth prospects, leading to a sell-off.
• The overall negative sentiment towards healthcare stocks, as evidenced by the performance of other healthcare companies like Elevance Health, could have also contributed to CNC's bearish movement.
• The reduction in stake by the Swiss National Bank in Elevance Health, a healthcare company, might have signaled broader concerns about the sector, impacting CNC's stock price negatively.

10.02.2026 - CNC Stock was down 8.9%

• Today's bearish movement in CNC stock can be attributed to a combination of factors:
• Concerns over regulatory issues with CMS regarding Medicare Advantage drug plans and an expected decline in Medicare Advantage members affecting future performance.
• A reduction in stake by institutional investors like the Swiss National Bank and Vinva Investment Management Ltd signaling uncertainties in Elevance Health's prospects, impacting CNC due to its association with the healthcare industry.
• Market reacting to the overall uncertainty in the healthcare sector and broader market sentiment, despite Centene Corporation reaffirming its 2026 financial guidance at the conference.
• Analysts' positive long-term outlook on Elevance Health's recovery and Centene's financial performance potentially offering support, though short-term concerns and market dynamics influencing CNC's bearish trend.